Literature DB >> 12622347

Variations in affect following amphetamine and placebo: markers of stimulant drug preference.

Frances H Gabbay1.   

Abstract

Variations in affect following d-amphetamine and placebo were examined in healthy young adults who subsequently preferred d-amphetamine (choosers; n = 61) or placebo (nonchoosers; n = 48) in a drug preference procedure. Affect was assessed before and 1, 3, and 6 hr after participants received the placebo and 10 mg d-amphetamine. Following amphetamine as compared with placebo, choosers' ratings increased on scales measuring energy, cognitive efficiency, and well-being, and decreased on scales measuring fatigue and sedation. Nonchoosers reported no effects, sedative effects, and dysphoric effects of amphetamine. Following placebo, ratings of energy, efficiency, and well-being decreased, and ratings of sedation increased in choosers but not in nonchoosers. Variations in affect following placebo and amphetamine may constitute markers of risk for drug use.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12622347     DOI: 10.1037//1064-1297.11.1.91

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  20 in total

Review 1.  Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.

Authors:  Colin N Haile; Thomas R Kosten; Therese A Kosten
Journal:  Am J Drug Alcohol Abuse       Date:  2009       Impact factor: 3.829

2.  Sex differences in drug-related stress-system changes: implications for treatment in substance-abusing women.

Authors:  Helen C Fox; Rajita Sinha
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

3.  Caffeine choice prospectively predicts positive subjective effects of caffeine and d-amphetamine.

Authors:  Stacey C Sigmon; Roland R Griffiths
Journal:  Drug Alcohol Depend       Date:  2011-05-19       Impact factor: 4.492

4.  Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use.

Authors:  Keith G Heinzerling; Steven Shoptaw
Journal:  Gend Med       Date:  2012-03-23

5.  Effects of amphetamine on reactivity to emotional stimuli.

Authors:  Margaret C Wardle; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2011-09-24       Impact factor: 4.530

Review 6.  Does a shared neurobiology for foods and drugs of abuse contribute to extremes of food ingestion in anorexia and bulimia nervosa?

Authors:  Walter H Kaye; Christina E Wierenga; Ursula F Bailer; Alan N Simmons; Angela Wagner; Amanda Bischoff-Grethe
Journal:  Biol Psychiatry       Date:  2013-02-04       Impact factor: 13.382

Review 7.  Behavioral genetic contributions to the study of addiction-related amphetamine effects.

Authors:  Tamara J Phillips; Helen M Kamens; Jeanna M Wheeler
Journal:  Neurosci Biobehav Rev       Date:  2007-11-29       Impact factor: 8.989

8.  The amphetamine response moderates the relationship between negative emotionality and alcohol use.

Authors:  Kenneth J D Allen; Frances H Gabbay
Journal:  Alcohol Clin Exp Res       Date:  2012-12-14       Impact factor: 3.455

9.  Ibudilast attenuates expression of behavioral sensitization to cocaine in male and female rats.

Authors:  Ryan S Poland; Yun Hahn; Pamela E Knapp; Patrick M Beardsley; M Scott Bowers
Journal:  Neuropharmacology       Date:  2016-06-22       Impact factor: 5.250

10.  Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers.

Authors:  Ajna Hamidovic; Andrea Dlugos; Abraham A Palmer; Harriet de Wit
Journal:  Behav Genet       Date:  2010-01-21       Impact factor: 2.805

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.